Introduction: Postpartum smoking relapse is a highly prevalent public health problem. Mood and breast feeding are significantly associated with smoking relapse, although less is known about the temporality of these relationships. Therefore, this study utilized ecological momentary assessments (EMA) to prospectively examine changes in mood and smoking-related symptomatology in relationship to three events-childbirth, termination of breast feeding, and smoking relapse. We expected all three events to significantly alter mood and smoking-related symptomatology.
significant relationships were observed, including a 96% increase in craving after smoking relapse. These novel observations can inform new and effective postpartum smoking relapseprevention programs.
Introduction
Although pregnancy is a strong motivator for smoking cessation, the majority of women who successfully quit smoking during pregnancy relapse soon after childbirth. [1] [2] [3] Current estimates suggest that 30-63% of women relapse within 6 months of childbirth, with over 70% relapsing within 1-2 years. [1] [2] [3] Postpartum smoking relapse is a significant public health concern, as it not only puts the mother at an increased likelihood of smoking-related morbidity and mortality but also exposes her children to secondhand smoke. [4] [5] [6] [7] Children exposed to secondhand smoke are at an increased risk of developing a wide range of negative health consequences from infancy (eg, sudden infant death syndrome) into adolescence and adulthood (eg, obesity). [4] [5] [6] [7] While a number of nonmodifiable (eg, age, education, and parity) and modifiable (eg, depression and breast feeding) postpartum smoking relapse predictors have been identified, effective postpartum smoking relapse-prevention programs are lacking. [8] [9] [10] Indeed, postpartum relapse rates have remained stagnant since 2000. 1 This suggests that a better understanding of the known and modifiable predictors and their relationship with smoking relapse, including the temporality of these relationships, may lead to the design of novel and more effective postpartum relapse-prevention interventions.
Elevated depressive symptoms are highly prevalent during the perinatal period and are one of the most consistent and well-studied risk factors for postpartum smoking relapse. [11] [12] [13] [14] During pregnancy, approximately one in three women experience elevated depressive symptoms, 15 which declines to one in ten women during the postpartum period. 16 Both a history of depressive symptoms and elevated depressive symptoms during the perinatal period have been shown to increase the risk of postpartum relapse, indicating depressive symptoms at any time, may be a risk factor for postpartum smoking relapse. 13, 17, 18 A recently published, large randomized clinical trial on postpartum smoking relapse compared an intervention that aimed to reduce depressive symptoms, and other risk factors, to a time-and attention-control condition. Unfortunately, there were no differences in postpartum smoking relapse rates, with 62% of the sample relapsing by postpartum week 12. 19 Other studies have examined the relationship between other aspects of mood with postpartum relapse. For example, the variation in affect during the perinatal period is influenced by the level of depressive symptoms, 20 and lower levels of positive affect have been linked to an earlier relapse during the postpartum period. 11 However, the understanding of the timing between changes in depressive symptoms, changes in other mood-related measures, and postpartum smoking relapse is underdeveloped.
Breast feeding has been implicated as a protective factor against postpartum smoking relapse. 2, 21, 22 While upward of 90% of new mothers initiate breast feeding after childbirth, by 6 months, the rates of breast feeding are approximately 50-60%, 23 indicating there is considerable termination of breast feeding during the first few months after delivery. The termination of breast feeding has been linked to postpartum smoking relapse in both qualitative and quantitative research. 2, 24 To date, much of the literature on the relationship between breast feeding and postpartum smoking relapse has relied on cross-sectional and/or retrospective self-reported data, which are highly susceptible to recall and social stigma bias as well as other forms of error. [25] [26] [27] Further, breast feeding itself is associated with a variety of smoking-relapse risk factors such as age and education level. 1, 2 Breast feeding also has a significant effect on the levels of sex hormones, 28 including progesterone, which has also been implicated as potentially protective against smoking relapse. 29 Thus, it is difficult to disentangle whether it is the breast feeding itself that is a protective factor against postpartum smoking relapse or if this observation is confounded by other variables.
To complicate these relationships further, breast feeding is intimately linked to depressive symptoms. Women who experience elevated depressive symptoms during the perinatal period tend to terminate breast feeding earlier. [30] [31] [32] Most (9/10) studies included in a recent meta-analysis found that postpartum depressive symptoms occurred prior to early breast-feeding discontinuation.
32 However, negative breast-feeding experiences can also precede onset of depressive symptoms. 32 Based on these data, it is impossible to know the temporality of the onset of depressive symptoms and termination of breast feeding and how they contribute to the risk for postpartum smoking relapse. It is also unknown how depressive symptoms and termination of breast feeding may influence other risk factors for smoking relapse such as smoking-related symptomatology (SRS; ie, craving) and affect. Understanding the temporal relationship of mood and SRS with easily identifiable clinical events (eg, childbirth, termination of breast feeding) and smoking relapse will provide necessary information to begin elucidating the causality of these factors; this knowledge will inform the development more effective and targeted postpartum relapse-prevention programs.
Ecological momentary assessment (EMA) is a data collection technique that is conducted at multiple timepoints over a set period of time within a participant's natural environment. 33 A major advantage of EMA is the reduction in recall and other biases by collecting "real-time" data. 33 While there is additional participant burden, given the need to complete assessments on a daily or more basis, this type of data collection has been recently demonstrated to be both feasible and acceptable during the postpartum period. 27 Further, EMA addresses many of the limitations to the current state of knowledge on predictors of postpartum smoking relapse by providing an opportunity to disentangle the temporality of these relationships while limiting biases. However, to date, no published studies have utilized EMA to examine postpartum smoking relapse.
Overall, while important risk factors (eg, depressive symptoms) and protective factors (eg, breast feeding) for postpartum smoking relapse have been identified, these data are critically limited, given methodological issues (e.g., cross-sectional or retrospective designs with a reliance on self-reported data) resulting in a high likelihood of a number of biases. Consequently, the knowledge regarding the timing of these factors in relationship with postpartum smoking relapse is underdeveloped. Therefore, the goals of this prospective investigation were to summarize the temporal relationships between three perinatal events (childbirth, termination of breast feeding, and smoking relapse), and to explore how mood and SRS changed from before to after these events. Given the primary goal of the parent pilot study was to conduct a preliminary exploration into the effectiveness of exogenous progesterone on smoking relapse during the postpartum period, 34 we were provided a unique opportunity to explore how exogenous progesterone may influence mood and SRS. Thus, we also explored exogenous progesterone's role as an effect modifier in the relationships between the three perinatal events and our outcomes. Detailed exploration into these relationships utilizing an EMA approach will inform the development of new postpartum smoking relapse-prevention programs.
Methods

Study Sample
In brief, a convenience sample of pregnant women was recruited in the metro area of Minneapolis/St. Paul, MN, via social media (eg, Facebook), Internet (eg, Craigslist), and mass media (eg, radio) advertising as well as flyers posted in local businesses and clinics and with word-of-mouth referrals. To be eligible, participants had to be healthy females between the ages of 18 and 35 with a single, uncomplicated pregnancy at gestational weeks 32-35. Participants also had to selfreport a recent history of smoking (5 or more cigarettes per day for at least 6 of the 12 past months), no current smoking (zero cigarettes smoked in the past month), and a motivation to remain abstinent after childbirth (7 or higher on a 10-point Likert-type scale). Eligibility was assessed via a phone interview followed by an in-person clinic visit, at which informed consent was also obtained. Additional details regarding eligibility criteria and enrollment can be found elsewhere. 34 
Study Procedures
At 36 weeks gestation, participants attended a Baseline Visit. At this visit participants were trained on how to complete daily ecological momentary assessments (EMA) using a customized version of the PiLR EMA software (MEI Research, Edina, Minnesota; http:// pilrhealth.com/). This application was either installed on the participant's personal smart phone or on a study-supplied smart phone. EMAs occurred once per day between the hours of 8 am and 10 pm (time randomly selected) as notified by a "beep." Participants then initiated daily EMA data collection the evening of their baseline visit and continued through week 12 postpartum. Each daily EMA took approximately 3 min to complete.
At 4 days postpartum, upon confirmation of smoking abstinence and established breast feeding (applicable only to those participants who initially expressed an intention to breastfeed), participants were randomly assigned to active (200 mg twice daily) or placebo progesterone for the first 4 weeks postpartum per the primary aim of the study. 34 Participants were then followed through 12 weeks postpartum by completing clinic visits at weeks 0, 2, 4, 8, and 12. At each clinic visit, participants completed timeline followback (TLFB) to report cigarettes smoked per day. 35, 36 Participants also completed weekly phone calls with study staff to troubleshoot any EMA issues, report cigarettes smoked per day using TLFB procedures, and receive brief relapse-prevention counseling.
Participants were compensated $1 per completed EMA with a bonus of $100 for completing 80% or more of assessments. Participants were also compensated for attending clinic visits ($40 in cash and gifts) and completing weekly phone calls ($5 cash per call, paid at next clinic visit) plus a $200 end of study bonus. All study procedures were approved by the Human Research Protection Program at the University of Minnesota. Additional details on study protocol can be found elsewhere. 34 
Study Measures
Our three independent variables were the events of childbirth, termination of breast feeding, and smoking relapse. The date of childbirth was captured via the EMA as participants clicked an "I had my baby" button upon delivery of their child, with confirmation by study staff at the week 0 visit. The date of breast-feeding termination was defined as the first day of a series of 4 days in which participants did not indicate breast feeding per EMA data. Smoking relapse was defined using the continuous abstinence definition (smoking a puff or more) per the TLFB data.
Our dependent variables, mood and smoking-related symptomatology, were assessed by two questionnaires that were delivered via EMA. The first is the Subjective State Scale 37,38 which was completed daily. This scale contained 24 items that yielded five subscales (range 0-7): craving, withdrawal, positive affect, negative affect, and physical symptoms (including single items on headache, stomach problems, sweating, and tremor). The second is the Edinburgh Postnatal Depression Scale 39 which was completed on a weekly basis, contained 10 items, and provided a score for depressive symptoms using a scale from 0 to 30.
Statistical Analysis
Descriptive statistics (means, standard errors, percentages, ranges, and so on) were used to describe the study sample and baseline levels of mood and smoking-related symptomatology. The first three days of EMA data were excluded to allow participants to get accustomed to the process. 40 Using a within-subject approach, each participant was compared to herself using the 30 days prior to the event of interest (childbirth, termination of breastfeeding or smoking relapse) compared to the 30 days after the event of interest. We selected to this 30-day window to utilize the full data collection period (eg, 30 days prior to delivery was approximately gestational week 36, the start of the data collection prior), and it provided adequate variability in changes in breastfeeding and smoking status. Overall patterns in mood were assessed descriptively by graphing scatter plots with a Loess smoother for mood versus days since event of interest. Mood outcomes were assessed for normality using histograms and QQ plots. Linear mixed models were used to test for a difference in mood and smoking-related symptoms by comparing before and after the event of interest, adjusting for progesterone (active/placebo) randomization. Mixed models contained a random intercept statement that included the event variable (before/after) and participant as the subject ID. To examine the change in mood outcomes from before to after each event of interest by progesterone (active/placebo) randomization, mixed models were run for each randomization group separately as well as together with a randomization by event interaction term. Generalized Estimating Equations (GEE) assuming autoregressive working correlation structures were used to compare overall mood levels over time between breast-feeding groups (continuously, termination during follow-up and none; first 60 days after childbirth) as well as between relapse groups (relapsed vs. abstinent; 30 days before/after relapse or first 60 days after childbirth). Breast-feeding GEEs were adjusted for cigarettes smoked per day on the day that the survey was completed (time-varying covariate) to adjust for any influence of cigarette smoking on outcomes. No imputed data were used in these models, per previous recommendations. 41 Analyses were completed using SAS software v. 9.4 (SAS Institute Inc., Cary, NC), and p values <.05 were considered statistically significant.
Results
Study Participants
Participants (n = 46) were, on average (mean ± standard error), 26.5 ± 0.8 years old and, prior to pregnancy, smoked 10.1 ± 0.7 cigarettes per day. Most were multiparous (59%), non-Hispanic (91%), and white (62%) with at least some college education (83%; Table 1 ). The first EMA was completed, on average, 23 days prior to childbirth (range 6-41 days). Average (± standard error) for mood and smoking-related symptomatology at this timepoint (i.e., baseline) were as follows: Craving 0.85 ± 0.25, Withdrawal 1.55 ± 0.18, Positive Affect 4.18 ± 0.27, Negative Affect 1.86 ± 0.23, Physical Symptoms 0.81 ± 0.25 and Depressive Symptoms 6.73 ± 0.70. Participants completed 84.46 ± 3.00% and 80.91 ± 2.28% of available EMAs during the prenatal and postpartum follow-up period, respectively. All initiated EMAs were fully completed (i.e., there were no partially completed EMAs).
Childbirth
All participants had live births without any major complications. Three of six outcomes significantly changed from the 30 days prior to childbirth to the 30 days after childbirth (Figure 1 ). Specifically, positive affect increased by 7% (β = 0.28 ± 0.11; p = .0165), whereas withdrawal (β = −0.26 ± 0.09; p = .0061) and negative affect (β = −0.44 ± 0.13; p = .0016) decreased by 17% and 24%, respectively (Table 2) . Among participants who were randomized to active progesterone (n=24), there were significant favorable changes in withdrawal (β = −0.40, 95% Confidence Interval [CI] = −0.61 to −0.18, p value = .0010), positive affect (β = 0.34, 95% CI = 0.02 to 0.65, p value = .0365), and negative affect (β = −0.65, 95% CI = −1.02to −0.28, p value = .0017) in 30 days after childbirth compared to 30 days prior to childbirth. In contrast, among participants randomized to placebo progesterone (n = 22), there were no statistically significant changes in any of the smoking-related symptomatology, and interaction term p values were not significant (data not shown).
Breastfeeding
Prior to childbirth, most participants reported an intent to breastfeed either exclusively (n = 29; 67%) or alternating with formula (n = 8; 19%). The remaining participants either indicated they did not want to breast-feed at all (n = 4; 9%) or were undecided (n = 2; 5%). Following childbirth, 38 (83%) participants initiated breast feeding and 23 were still breast feeding at the end of the 12-week follow-up. Of the 15 who terminated breast feeding during followup, termination occurred, on average, 34.5 ± 6.3 days after childbirth (range: 4-78 days after childbirth). The remaining participants either did not breast-feed at all (n = 5) or had missing breast-feeding data (n = 3).
When comparing those who consistently breast-fed during the follow-up period (n = 23), those who did not breast-feed at all (n = 5) reported consistently lower levels of withdrawal (β = −0.61 ± 0.24; p = .0102), negative affect (β = −0.70 ± 0.23; p = .0025), and physical symptoms (β = −0.64 ± 0.17; p = .0001) after adjusting for cigarettes smoked per day (Figure 2 ). While there were no statistically significant differences between participants who consistently breast-fed (n = 23) versus those who terminated breastfeeding during the study (n = 15), those who terminated breast feeding during the study had consistently higher levels of withdrawal, negative affect, and depressive symptoms as well as consistently lower levels of positive affect.
No significant differences were observed in mood or smokingrelated symptomatology between the 30 days prior to the termination of breast feeding compared to the 30 days after among those who terminated during follow-up (n = 15). Among those randomized to active progesterone (n = 8), there were no statistically significant changes in any of the smoking-related symptomatology. In contrast, among those randomized to placebo (n = 7), there was a significant decrease in withdrawal (β = −0.43, 95% CI = −0.84 to −0.03, p value = .0413), when comparing the 30 days prior to termination of breast feeding to the 30 days after. There were no other significant changes in mood from before to after smoking relapse when stratified by randomization, and interaction term p values were not significant (data not shown).
Smoking Relapse
Half (23/46) of the participants relapsed to smoking during followup. Among the participants who relapsed to smoking during followup, average days to relapse after childbirth was 34.9 ± 5.4 days (range: 4-88 days after childbirth). Of the 23 participants who relapsed, 22 had complete breast-feeding data. One participant did not breast-feed at all, 4 relapsed before terminating breast feeding (average ± SD, 21 ± 22 days before; range 1-53 days before), 5 relapsed after terminating breast feeding (average ± SD, 24 ± 26 days after; range 2-68 days after), and 12 participants continuously breast-feed during the 12-week follow-up.
Compared to those who relapsed during follow-up (n = 23), those who remained abstinent (n = 23) had significantly lower craving (β = −1.19 ± 0.34; p = .0004), withdrawal (β = −0.67 ± 0.25; p = .0081), negative affect (β = −0.82 ± 0.28; p = .0039), and physical symptoms (β = −0.44 ± 0.18; p = .0176) throughout the follow-up period ( Figure 3 ). While there were no statistical differences in depressive symptoms, those who remained abstinent reported a steady decline in their depressive symptoms after childbirth, whereas those who relapsed reported a gradual increase in depressive symptoms from childbirth to smoking relapse, after smoking relapse depressive symptoms declined. Among those who relapsed (n = 23), when comparing the 30 days prior to the relapse to the 30 days after, relapse was associated with a significant increase in two of the six mood items-craving nearly doubled, increasing by 96% (β = 0.82 ± 0.24; p = .0023) and positive affect increased by 5% (β = 0.20 ± 0.09; p = .0440). There was a significant interaction between randomization and change in positive affect after smoking relapse (p = .0272) such that participants randomized to progesterone (n = 12) had a significant increase in positive affect (β = 0.42, 95% CI = 0.13 to 0.70, p value = 0.0087) while those who were randomized to placebo (n = 11) did not (β = 0.03, 95% CI = −0.24 to 0.29, p value = .8251). Further, those who were randomized to progesterone did not have a significant change in craving upon smoking relapse (β = 0.63, 95% CI = −0.35 to 1.62, p value = .1824), whereas those randomized to placebo had a significant increase in craving after smoking relapse (β = 1.06, 95% CI = 0.62 to 1.49, p value = .0003), although this interaction term was not statistically significant (p value = .2739). There were no other significant changes in mood from before to after smoking relapse when stratified by randomization nor were any other interaction terms significant (data not shown). 
Discussion
This study is among the first to utilize ecological momentary assessments (EMA) to evaluate the change in mood and smoking-related symptomatology during the postpartum period among women who had quit smoking during pregnancy, noting a number of significant within-subject effects of childbirth, terminating of breast feeding and smoking relapse, as well as between-subject differences based on breast-feeding practices and smoking relapse. First, craving for cigarettes was only altered by the event of smoking relapse and not by childbirth or termination of breast feeding. Compared to those who remained abstinent, those who relapsed to smoking had about 1 point higher craving immediately after childbirth, which was, on average, about 20-30 days prior to smoking relapse. At 30 days after relapse, or approximately 2 months postpartum, those who relapsed to smoking reported craving as 2 points higher compared to those who did not relapse. This concurs with previous literature, as an overwhelming craving for cigarettes has been commonly cited as a reason for postpartum relapse. 24 Further, prior work has also indicated that craving during the third trimester significantly predicts postpartum smoking relapse in a sample of lower socioeconomic status women, beyond levels of negative affect and agency (e.g., self-efficacy). 42 These data suggest that heightened craving, prior to relapse, may serve as a way to identify those who may be at increased risk for postpartum relapse. Interestingly, smoking relapse did not significantly alter craving for cigarettes among those who were on active exogenous progesterone. Progesterone has been shown to blunt craving for other drugs, 29, 43 although this has not yet been demonstrated in the postpartum period as we do here. Thus, future fully powered study should explore the potential protective effect of progesterone on postpartum smoking relapse. Further, novel postpartum relapse-prevention programs should incorporate measures that directly address combating craving. For example, utilizing short bouts of exercise, which have been shown to significantly reduce craving in the general population of smokers, 44 may be a useful strategy to prevent postpartum smoking relapse.
Withdrawal symptomatology was significantly influenced by all three-childbirth, breast feeding, and smoking relapse. Withinsubject analyses identified a significant decline in withdrawal symptoms after birth. Between-subject analyses identified lower withdrawal in those who did not breast-feed and those who remain abstinent from smoking. Given that withdrawal is a subscale comprised of items that overlap with symptoms that normally occur during the postpartum period (e.g., hunger, sleep problems, and anxiety), it is no surprise that this subscale was altered by childbirth. It is, however, unexpected that those who did not breast-feed reported significantly lower levels of withdrawal compared to women who were consistently breast feeding. However, only five women did not breast-feed at all, and, therefore, it is plausible that the observations obtained from these five women may not be generalizable to all women who do not breastfeed. This observation needs to be replicated in larger samples. In contrast, women who relapsed to smoking reported significantly greater withdrawal. Nicotine dependence, which likely was reestablished quickly after postpartum smoking relapse, is characterized by continuously cycling in and out of acute smoking withdrawal. 45 Thus, increases in these symptoms postrelapse is as expected, especially if they were making strong efforts to limit their consumption. Perhaps one seemingly counterintuitive though potentially salient message that could be conveyed to new mothers in postpartum smoking relapse-prevention programs is that smoking a cigarette during postpartum will not likely improve smoking-related symptomatology, whether it be craving or other withdrawal symptoms.
Positive and negative affects were also influenced by all three events. Within-subject analyses showed that childbirth had significant and favorable effects on both positive and negative affect. Those who breast-fed consistently had lower levels of negative affect but no difference in positive affect. Smoking relapse had a conflicting effect on affect. Positive affect significantly increased during the 30 days after relapse compared to the 30 days prior to relapse. Conversely, negative affect was significantly lower among those who abstained from smoking compared to those who relapsed. Levine and colleagues 11 previously reported that lower levels of positive affect are linked to early postpartum smoking relapse. We did not observe any difference in positive affect between those who relapsed and those who did not. The difference was more prominent in negative affect in that those who relapsed had consistently higher negative affect, although the event of relapse did not influence negative affect.
Interestingly, depressive symptoms were not significantly associated with any of the three events in either the within-or the betweensubject analyses. However, a qualitative comparison of the effect of these three events on depressive symptoms is intriguing. Depressive symptoms increased dramatically during approximately 20-10 days prior to childbirth and then plunged immediately before childbirth. Immediately after childbirth depressive symptoms decline until approximately 10 days postpartum when they begin to climb again. In contrast, the effect of breast feeding on depressive symptoms seems to be most dramatic among those who did not breast-feed at all. Those who consistently and partially breast-fed experienced a steady, though slow, decline in depressive symptoms after delivery. Those who did not breast-feed at all had a dramatic decline during the first 10 days postpartum. Finally, and perhaps most striking is the distinctly different pattern of depressive symptoms among those who relapsed to smoking versus those who did not. Participants who remained abstinent from smoking experienced a consistent and gradual decline in depressive symptoms soon after childbirth. In contrast, participants who relapsed experienced higher depressive symptoms immediately after childbirth, which peaked at time of smoking relapse and then declined drastically to meet the levels reported among those who did not relapse. Although these patterns were not statistically significant, further investigation is warranted, especially given that our study sample, overall, had low levels of depressive symptoms. Exploration into the effect of these events within a sample that is at high risk of postpartum depression (e.g., those with high prenatal depressive symptoms or a history of major depressive disorder) may yield different and, potentially more dramatic, results. Given those who are at high risk of postpartum depression are also those who are at high risk of postpartum relapse, 13, 17, 18 understanding these complex patterns is of public health importance.
We also explored progesterone as an effect modifier of the effect of the event (eg, childbirth, termination of breast feeding, and smoking relapse) on smoking-related symptomatology. Those who were randomized to active progesterone had favorable changes in withdrawal and affect after childbirth and smoking relapse and, perhaps, a blunted increase in craving after smoking relapse. Progesterone is thought to have protective effects against drug-taking behaviors. 29, 46 Therefore, given the dramatic decline in progesterone from the end of pregnancy to early postpartum, 47 the parent project explored exogenous progesterone as a postpartum smoking relapse-prevention technique. 34 The observations in the present project suggest that the delivery of exogenous progesterone during the postpartum period may have favorable effects on the change in smoking-related symptomatology primarily from pregnancy to postpartum, including a blunting of craving after postpartum smoking relapse. Future work should investigate the protective effects of progesterone on postpartum smoking relapse and the possible mechanisms of action.
Although this study is strengthened by the both the use of ecological momentary assessments, which limits recall bias and offers frequent sampling, 33 aand the high compliance with this relatively cumbersome protocol similar to previous work 27 and the longitudinal study design, there are limitations worth nothing. First, the sample size is fairly small and rather homogenous. This is especially worth noting in our between-subject comparisons (eg, only five participants in the study did not breast-feed at all). It is unknown how these observations may generalize to other populations. Further, it is not known how these observations may apply to women who are at high risk for postpartum smoking relapse due to a number of nonmodifiable risk factors (eg, race, parity, education, and household smoking). Future work should explore how these nonmodifiable risk factors may interact with those we are able to modify (eg, breast feeding and mood). Second, the date of smoking relapse and termination of breast feeding was defined using self-reported data, without biochemical confirmation. These variables are prone to bias due to social stigma and other factors. Therefore, these data may contain errors. Finally, our follow-up was limited to 12 weeks postpartum. It is entirely possible that additional smoking relapse occurred after our follow-up period concluded. Given these limitations, future research should include a larger, more diverse study sample with biologic confirmation of study outcomes with a longer follow-up time.
In conclusion, these data provide evidence that childbirth, breastfeeding practices and smoking relapse all significantly influence both mood and smoking-related symptomatology during the postpartum period. Our observations may inform future research and the development of novel smoking relapse interventions that can address these changes in mood and symptomatology. Addressing these changes preemptively may lead to decreases in postpartum smoking relapse.
